Fellowship is one of the most distinguished designations the Heart Failure Society of America (HFSA) can offer its members. It is a tremendous recognition of professional achievement and contributions to the society. The designation is based on outstanding credentials, achievements, and contributions to heart failure medicine.
Those who are elected to fellowship, demonstrate to peers and patients their commitment to quality heart failure care through use of the fellowship heart failure society designation (FHFSA). Fellow participants enhance their knowledge of heart failure issues and obtain valuable professional experience that enriches their careers.
Letters of reference from three leaders in heart failure were provided to attest to these items. The letters describe being known in the field as a heart failure expert through active publishing, presentation and awards related to heart failure research. Involvement with scientific societies as well as the Myocarditis Foundation. Involvement and commitment specifically to the HFSA through presenting at meetings, chairing sessions, serving as an abstract reviewer, serving on committees, and leading incentives.
Dr. Fairweather, PhD, is Director of Translational Research in the Dept. of Cardiovascular Medicine at Mayo Clinic in Jacksonville, Florida. She has worked with the Myocarditis Foundation for many years and is on our Medical Advisory Board. She has recently received a RO1 Grant from the National Institute of Health to further her research. Funding for this type of grant is extremely competitive, and only 10% of the grant requests are funded. Often an RO1 grant is behind many “best practices” and interventions considered “standard of care”. Her RO1 grant research is on Sex Differences in Mitochondria.
Dr. Katelyn Bruno, PhD, is an Assistant Professor of Cardiovascular Medicine in the Division of Cardiovascular Medicine (Department of Medicine), Department of Physiology and Aging and Center for Regenerative Medicine at the University of Florida. She too has worked with the Myocarditis Foundation in various capacities for several years and is currently the Secretary to the Medical Advisory Board.
The Myocarditis Foundation would like to congratulate and thank them both for all that they have done to further the science of Myocarditis.
